A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/438 (2006.01) A61K 31/4439 (2006.01) A61P 1/04 (2006.01)
Patent
CA 2616941
The invention relates to the combination of the cholecystokinin-2 (CCK-2) receptor antagonist Itriglumide and proton pump inhibitors (PPIs) for the treatment of patients suffering from gastrointestinal and related disorders.
L'invention a pour objet la combinaison de l~antagoniste Itriglumide du récepteur de la cholécystokinine-2 (CCK-2) et d~inhibiteurs de la pompe à proton (IPP) pour le traitement de patients souffrant de troubles gastro-intestinaux et apparentés.
Caselli Gianfranco
D'amato Massimo Maria
Giordani Antonio
Makovec Francesco
Rovati Lucio Claudio
Macrae & Co.
Rottapharm S.p.a.
LandOfFree
Combination of itriglumide and proton pump inhibitors in the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination of itriglumide and proton pump inhibitors in the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of itriglumide and proton pump inhibitors in the... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1865265